TEDA Investment News: September 2009

Tuesday, September 15, 2009 23:25
Posted in category Uncategorized
Comments Off on TEDA Investment News: September 2009

NOVOZYMES TO MAKE TIANJIN ITS GLOBAL PROCUTION CENTER
Novozymes (China) Biotechnology Co., Ltd. will soon expand production again in TEDA to build Tianjin into its global strategic production base.
A highlight of the local biopharmaceutical industry, Novozymes (China) Biotechnology is invested by Novozymes, a Danish giant in industrial enzymes (occupying 45% of the global market) and micro-biological preparations. It has been engaged in the R&D, production and marketing of enzymes since incorporated in TEDA in 1994. The Tianjin subsidiary is Novozymes’ third largest strategic enzyme production base after Denmark and the United States. The current expansion, scheduled to be finished in 2010 to triple its granulation capacity, will involve 5,599 square meters of new floor area and 380 million yuan of reinvestment.

Since launching production in 1998, the local Novozymes facility has been renovated and expanded several times and now supplies a wide portfolio of enzyme products to food, brewing, and detergent industries. The company gives balanced attention to production scale and environmental protection. It ranks number one among TEDA’s top ten environment-friendly enterprises for three years in a row.(Tr. By Zhang Shanshan)

CHINA SURGICAL INSTRUMENTS (CHINA) CORPORATION REGISTERS IN TEDA
As a subsidiary of China Surgical (Cayman) Corporation, China Surgical Instruments (China) Co, Ltd. was recently incorporated in TEDA.

The new company, with a total investment of 18.75 million dollars (a registered capital of 7.5 million dollars), will be built into the mass production center for micro-invasive surgical instruments of China Surgical Corporation in Tianjin. Its product portfolio may cover approximately 20 specifications such in general surgery, chest surgery, gynecology, obstetrics, etc. Once becoming operational, it is expected to yield an annual output of 100 million yuan and export 20% of its products to the overseas market.

A micro-invasive surgery training center will be launched after the Phase-I realizes full production, striving to build the Tianjin base into Asia’s biggest producer and developer of micro-invasive surgical instruments in five years. ( Tr. By Zhang Shanshan)

SCOPE INTERNATIONAL CHINA BREAKS EARTH FOR TIANJIN OFFICE
Recently, Scope International China broke earth for its Tianjin office building at the TEDA Service Outsourcing Industrial Park.

As a wholly-owned subsidiary of Standard Chartered Bank (Hong Kong) Ltd., Scope China is currently located in the Tianjin University Science Park. It started operation on July 19th, 2007 and now employs over 300 people for data outsourcing services. Tianjin is the third city to have a Scope International after Kuala Lumpur, Malaysia and Chennai, India.

The Tianjin office building, comprising a seven-story east tower and a five-story west tower with a total floor area of 16,500 square meters, will be delivered in 2010 as a property of Scope International China. (Tr. by Zhang Shanshan)

TEDA’S 1ST MICRO LOAN COMPANY SET UP
Tianjin Hanneng Samll Loan Co., Ltd. applied for establishment and got approval in TEDA on August 13th, 2009. It is the first RMB micro loan company in TEDA jointly funded by enterprise legal person and natural person without absorbing public saving. It is also one of the city’s pilot micro loan companies in an effort to expand financing channels, ease the financing difficulties of small enterprises and micro agriculture loans, and promote the tri-party interaction and coordination between the Tianjin Binhai New Area (TBNA), urban districts, and suburban districts and counties.

The TBNA has been approved by the State Council to serve as a pilot farm for China’s financial reform. It is entrusted with financial innovation tasks such as direct financing expansion, financial service system updating, and pilot universal banking. Tianjin Hanneng made a timely entry into this high growth region to add more fuel to the local capital market and financial environment. It plans to focus on serving rural communities, agriculture, and peasants, and explore and provide micro loans as well as related consultancy services to small and medium-sized enterprises, urban and rural residents. (Tr. by Zhang Shanshan)

CHINESE LEGAL PERSON OF KOREA EXCHANGE BANK RECENTLY APPROVED BY CHINA BANKING REGULATORY COMMISSION
Mr. Ni Xiangyu, Chairman of the TEDA Administrative Commission, recently met the delegation led by Mr. Lee Kwang Hyun, Manager of Tianjin Branch of Korea Exchange Bank.

Korea Exchange Bank recently has obtained an approval from China Regulatory Commission and officially begun to prepare for the establishment of its Chinese legal person and headquarters. With expected registered capital of 300 million dollars (2.2 billion yuan or so), its Chinese headquarters will be temporarily located in downtown Tianjin and later move to the TEDA after the completion of the TEDA MSD. After the present intensive preparations, the headquarters is expected to open at the end of 2009. Following Industrial Bank of Korea, Korea Exchange Bank will not only become the second foreign bank’s Chinese headquarters in Tianjin which is at the level of head office and has an independent accounting system but the first foreign bank’s Chinese headquarter in the TBNA.

Korea Exchange Bank, established in 1967, was a state-owned bank engaged in foreign exchange business. In 1989 it became a private bank, with 314 domestic branches, 18 foreign branches and 10 legal persons. It is the first bank in South Korea that operated international settlement business. After the establishment of its Chinese legal person, the bank will comprehensively expand in corporate and personal finance, credit card, etc. (Tr. by Chen Yu)

THE COMPANY IN CHARGE OF THE CONSTRUCTION AND OPERATIONS OF TIANJIN PORT CONTAINER TERMINAL REGISTERED AND ESTABLISHED IN TEDA
Tianjin China Railway Joint International Container Co., Ltd., the company in charge of the construction and operations of Tianjin Port Container Terminal, was recently registered and established in TEDA. The company specializes on the operations of the Terminal, including arrival and departure, loading and unloading, assembly, stuffing and unstuffing, storage, repair, etc. in the Terminal, marine, land, and air freight forwarding and multimodal forwarding, and contracted operations of scheduled container trains.

China Railway Container Transport Corp. Ltd., the main shareholder of Tianjin China Railway Joint International Container Co., Ltd., is a Chinese-foreign JV, established upon the approval of the National Development and Reform Commission. The company is engaged in the construction and operations of 18 railway container terminals in 18 cities across the country. After its completion, Tianjin China Railway Joint International Container Co., Ltd. will be responsible for the construction and operations of Tianjin Port Container Terminal, the third railway to the Port, and the extended railway to the Dongjiang Dock, the railway freight project in the general cargo wharf of the northern basin of Tianjin Port, the reconstruction of the extended railway of West Beitang. It is one of the top 20 key transport projects in Tianjin. (Tr. by Chen Yu)

INVESTMENT IN THE NANGANG INDUSTRIAL ZONE TO REACH 800 BILLION YUAN, OFFERING 200,000 JOBS
According to the related departments, as an important carrier to implement the strategy of “two ports and two cities”, the Nangang Industrial Zone will follow the standard of a world-class industrial zone in its construction. After its completion, the Zone is expected to accumulatively absorb a total investment of 800 billion yuan, contribute a total output value of one trillion yuan, and directly create nearly 200,000 jobs.

As a new economic growth engine of the Tianjin Binhai New Area, the Zone has begun its all-around construction. Everyday tens of thousands of construction vehicles shuttle in the Zone. It is expected that within the year five large projects will begin their construction. The Zone will comprise one zone, one belt, and five parks. There will be a nearly one km-wide greenbelt between the west side of Jinqi Road and Guangming Avenue.

The five parks are Petrochemical Industrial Park, Metallurgical Equipment Manufacturing Park, Comprehensive Industrial Park, Port Logistics Park, and Public Utility Park, each of which is comprised of industrial clusters with different functions.

It is expected that by 2020, after the completion of its construction, the Zone may accumulatively draw a total investment of 800 billion yuan, contribute an output value of one trillion yuan, a total industrial added value of 350 billion yuan, and taxes and profits of 200 billion yuan. By then, the Zone will reach or approach the internationally advanced level in energy consumption of key products and directly create nearly 200,000 employment opportunities. (Tr. by Chen Yu)

BIOPHARMACEUTICAL INDUSTRY OF TEDA INCREASINGLY CLUSTERED IN 2009
At present China Surgical Instruments (China) Corporation, a leading foreign surgical instrument provider founded by Mr. Fang Yuncai, a returned PhD from the US, and China Renaissance Capital Investment (CRCI) has launched a surgical instrument industrialization project, with a total investment of 18.75 million dollars. After its completion, it will help TEDA develop a first-class production base of MIS apparatus and instruments.
This year TEDA has seen robust and increasingly clustered development in its biopharmaceutical industry, highlighting the biopharmaceutical industry as one of the leading industries of TEDA.

From Jan. to Jul. this year, compared with the same period of last year, six new biopharmaceutical companies (up by 20%) have been set up in TEDA, with a total investment of 79.7986 million dollars (up by 54.78%) and registered capital of 32.1980 million dollars (up by 20.46%). Among them there are investment increase projects of world-famous pharmaceutical companies such as Novozymes Biopharma Co, Ltd., and new biopharmaceutical R&D and testing companies, such as Kangxinuo, Hanmeng, Daming Biosciences, etc.

The rapid development of TEDA’s biopharmaceutical industry is closely related to the very competitive investment policies and investment environment that TEDA has fostered over a long period of time. Meanwhile, favorable factors like the establishment of Tianjin Joint Academy of Biotechnology and Medicine, the opening of 2009 International Conference for Bioeconomy in TEDA, etc. have accelerated the clustering process in TEDA’s biopharmaceutical industry. (Tr. by Chen Yu)

Both comments and pings are currently closed.